Annual EBITDA:
$23.50B+$11.91B(+102.87%)Summary
- As of today, PFE annual EBITDA is $23.50 billion, with the most recent change of +$11.91 billion (+102.87%) on December 31, 2024.
- During the last 3 years, PFE annual EBITDA has fallen by -$2.49 billion (-9.58%).
- PFE annual EBITDA is now -44.86% below its all-time high of $42.61 billion, reached on December 31, 2022.
Performance
PFE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$7.19B+$1.99B(+38.31%)Summary
- As of today, PFE quarterly EBITDA is $7.19 billion, with the most recent change of +$1.99 billion (+38.31%) on September 28, 2025.
- Over the past year, PFE quarterly EBITDA has increased by +$469.00 million (+6.98%).
- PFE quarterly EBITDA is now -49.07% below its all-time high of $14.12 billion, reached on June 1, 2022.
Performance
PFE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$26.15B+$469.00M(+1.83%)Summary
- As of today, PFE TTM EBITDA is $26.15 billion, with the most recent change of +$469.00 million (+1.83%) on September 28, 2025.
- Over the past year, PFE TTM EBITDA has increased by +$9.12 billion (+53.51%).
- PFE TTM EBITDA is now -39.33% below its all-time high of $43.10 billion, reached on December 31, 2022.
Performance
PFE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PFE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +102.9% | +7.0% | +53.5% |
| 3Y3 Years | -9.6% | -33.9% | -35.9% |
| 5Y5 Years | +76.6% | +94.0% | +73.0% |
PFE EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -44.9% | +102.9% | -33.9% | +597.4% | -39.3% | +194.9% |
| 5Y | 5-Year | -44.9% | +102.9% | -49.1% | +597.4% | -39.3% | +194.9% |
| All-Time | All-Time | -44.9% | +3974.2% | -49.1% | +324.1% | -39.3% | +1290.6% |
PFE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $7.19B(+38.3%) | $26.15B(+1.8%) |
| Jun 2025 | - | $5.20B(-16.7%) | $25.68B(+6.6%) |
| Mar 2025 | - | $6.24B(-17.0%) | $24.09B(-0.2%) |
| Dec 2024 | $23.50B(+102.9%) | $7.52B(+11.8%) | $24.14B(+41.7%) |
| Sep 2024 | - | $6.72B(+86.2%) | $17.04B(+92.1%) |
| Jun 2024 | - | $3.61B(-42.7%) | $8.87B(-3.4%) |
| Mar 2024 | - | $6.29B(+1446.7%) | $9.18B(-17.0%) |
| Dec 2023 | $11.58B(-72.8%) | $407.00M(+128.1%) | $11.06B(-36.9%) |
| Sep 2023 | - | -$1.45B(-136.9%) | $17.52B(-41.3%) |
| Jun 2023 | - | $3.92B(-52.0%) | $29.84B(-25.5%) |
| Mar 2023 | - | $8.17B(+19.0%) | $40.04B(-7.1%) |
| Dec 2022 | $42.61B(+64.0%) | $6.87B(-36.9%) | $43.10B(+5.7%) |
| Sep 2022 | - | $10.88B(-22.9%) | $40.79B(+4.6%) |
| Jun 2022 | - | $14.12B(+25.8%) | $39.00B(+21.2%) |
| Mar 2022 | - | $11.23B(+146.4%) | $32.17B(+19.3%) |
| Dec 2021 | $25.98B(+88.8%) | $4.56B(-49.9%) | $26.96B(+10.3%) |
| Sep 2021 | - | $9.09B(+24.6%) | $24.43B(+28.3%) |
| Jun 2021 | - | $7.30B(+21.2%) | $19.05B(+23.2%) |
| Mar 2021 | - | $6.02B(+196.6%) | $15.46B(+12.7%) |
| Dec 2020 | $13.77B(+3.5%) | $2.03B(-45.3%) | $13.72B(-9.3%) |
| Sep 2020 | - | $3.71B(-0.1%) | $15.12B(-7.4%) |
| Jun 2020 | - | $3.71B(-13.1%) | $16.33B(-11.0%) |
| Mar 2020 | - | $4.27B(+24.6%) | $18.35B(-8.8%) |
| Dec 2019 | $13.31B(-38.6%) | $3.43B(-30.4%) | $20.13B(-6.8%) |
| Sep 2019 | - | $4.92B(-14.1%) | $21.59B(-2.7%) |
| Jun 2019 | - | $5.73B(-5.2%) | $22.18B(+0.5%) |
| Mar 2019 | - | $6.04B(+23.4%) | $22.07B(+2.0%) |
| Dec 2018 | $21.67B(+4.9%) | $4.90B(-11.1%) | $21.65B(+4.0%) |
| Sep 2018 | - | $5.51B(-2.0%) | $20.81B(+0.3%) |
| Jun 2018 | - | $5.63B(+0.2%) | $20.75B(+0.9%) |
| Mar 2018 | - | $5.62B(+38.4%) | $20.57B(-0.4%) |
| Dec 2017 | $20.66B(+3.1%) | $4.06B(-25.5%) | $20.66B(-0.2%) |
| Sep 2017 | - | $5.45B(0.0%) | $20.70B(+1.8%) |
| Jun 2017 | - | $5.45B(-4.6%) | $20.32B(+0.7%) |
| Mar 2017 | - | $5.71B(+39.3%) | $20.17B(+0.7%) |
| Dec 2016 | $20.03B(+8.6%) | $4.10B(-19.2%) | $20.03B(+1.5%) |
| Sep 2016 | - | $5.07B(-4.2%) | $19.74B(-1.0%) |
| Jun 2016 | - | $5.30B(-4.9%) | $19.94B(+1.7%) |
| Mar 2016 | - | $5.57B(+46.4%) | $19.60B(+6.2%) |
| Dec 2015 | $18.45B(-5.7%) | $3.80B(-27.9%) | $18.46B(+0.4%) |
| Sep 2015 | - | $5.28B(+6.5%) | $18.38B(+0.9%) |
| Jun 2015 | - | $4.96B(+12.1%) | $18.22B(-3.6%) |
| Mar 2015 | - | $4.42B(+18.6%) | $18.90B(-3.4%) |
| Dec 2014 | $19.57B(-16.0%) | $3.73B(-27.1%) | $19.56B(-7.9%) |
| Sep 2014 | - | $5.11B(-9.2%) | $21.25B(-3.3%) |
| Jun 2014 | - | $5.63B(+10.7%) | $21.96B(-2.1%) |
| Mar 2014 | - | $5.09B(-6.0%) | $22.44B(-4.6%) |
| Dec 2013 | $23.30B(-9.3%) | $5.41B(-7.1%) | $23.53B(-1.9%) |
| Sep 2013 | - | $5.83B(-4.6%) | $23.98B(-1.4%) |
| Jun 2013 | - | $6.11B(-1.1%) | $24.31B(-4.3%) |
| Mar 2013 | - | $6.18B(+5.3%) | $25.41B(-4.8%) |
| Dec 2012 | $25.69B(-6.3%) | $5.87B(-4.8%) | $26.69B(-2.4%) |
| Sep 2012 | - | $6.16B(-14.5%) | $27.34B(-5.7%) |
| Jun 2012 | - | $7.21B(-3.4%) | $29.01B(-0.2%) |
| Mar 2012 | - | $7.46B(+14.6%) | $29.05B(+0.9%) |
| Dec 2011 | $27.41B(+4.5%) | $6.51B(-16.8%) | $28.79B(+3.7%) |
| Sep 2011 | - | $7.83B(+7.9%) | $27.75B(+3.8%) |
| Jun 2011 | - | $7.25B(+0.8%) | $26.74B(-1.1%) |
| Mar 2011 | - | $7.20B(+31.3%) | $27.05B(+2.6%) |
| Dec 2010 | $26.22B(+26.3%) | $5.48B(-19.6%) | $26.37B(+1.3%) |
| Sep 2010 | - | $6.82B(-9.8%) | $26.05B(+5.9%) |
| Jun 2010 | - | $7.56B(+16.0%) | $24.60B(+12.8%) |
| Mar 2010 | - | $6.52B(+26.4%) | $21.81B(+5.0%) |
| Dec 2009 | $20.77B(-4.4%) | $5.16B(-4.0%) | $20.77B(-2.5%) |
| Sep 2009 | - | $5.37B(+12.7%) | $21.31B(-0.1%) |
| Jun 2009 | - | $4.77B(-12.8%) | $21.33B(-1.0%) |
| Mar 2009 | - | $5.47B(-3.9%) | $21.54B(-0.8%) |
| Dec 2008 | $21.71B(+13.6%) | $5.70B(+5.6%) | $21.71B(+7.3%) |
| Sep 2008 | - | $5.39B(+8.3%) | $20.23B(+16.2%) |
| Jun 2008 | - | $4.98B(-11.8%) | $17.41B(+5.9%) |
| Mar 2008 | - | $5.65B(+34.1%) | $16.43B(-3.2%) |
| Dec 2007 | $19.12B(-6.2%) | $4.21B(+63.4%) | $16.98B(+0.6%) |
| Sep 2007 | - | $2.58B(-35.7%) | $16.88B(-14.3%) |
| Jun 2007 | - | $4.00B(-35.3%) | $19.68B(-5.0%) |
| Mar 2007 | - | $6.19B(+50.8%) | $20.73B(+2.6%) |
| Dec 2006 | $20.39B(+1.4%) | $4.11B(-23.7%) | $20.20B(-5.5%) |
| Sep 2006 | - | $5.38B(+6.6%) | $21.38B(+2.2%) |
| Jun 2006 | - | $5.05B(-10.8%) | $20.92B(+1.1%) |
| Mar 2006 | - | $5.66B(+7.2%) | $20.70B(+0.3%) |
| Dec 2005 | $20.11B(-9.4%) | $5.28B(+7.4%) | $20.63B(-7.2%) |
| Sep 2005 | - | $4.92B(+1.9%) | $22.22B(-3.3%) |
| Jun 2005 | - | $4.83B(-13.6%) | $22.99B(+1.1%) |
| Mar 2005 | - | $5.59B(-18.6%) | $22.74B(+0.3%) |
| Dec 2004 | $22.18B | $6.88B(+20.8%) | $22.68B(+6.2%) |
| Sep 2004 | - | $5.69B(+24.2%) | $21.34B(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $4.58B(-17.1%) | $19.37B(+6.3%) |
| Mar 2004 | - | $5.53B(-0.3%) | $18.21B(+10.7%) |
| Dec 2003 | $17.76B(+33.0%) | $5.54B(+49.4%) | $16.45B(+13.7%) |
| Sep 2003 | - | $3.71B(+8.2%) | $14.47B(+1.6%) |
| Jun 2003 | - | $3.43B(-9.0%) | $14.23B(+4.2%) |
| Mar 2003 | - | $3.77B(+5.8%) | $13.66B(+2.4%) |
| Dec 2002 | $13.35B(+12.5%) | $3.56B(+2.4%) | $13.35B(+5.9%) |
| Sep 2002 | - | $3.48B(+21.5%) | $12.60B(+3.0%) |
| Jun 2002 | - | $2.86B(-17.1%) | $12.24B(-0.1%) |
| Mar 2002 | - | $3.45B(+22.8%) | $12.26B(+3.3%) |
| Dec 2001 | $11.87B(+24.4%) | $2.81B(-9.6%) | $11.87B(+3.1%) |
| Sep 2001 | - | $3.11B(+8.1%) | $11.52B(+5.4%) |
| Jun 2001 | - | $2.88B(-6.2%) | $10.93B(+6.3%) |
| Mar 2001 | - | $3.07B(+24.8%) | $10.27B(+16.8%) |
| Dec 2000 | $9.54B(+88.0%) | $2.46B(-2.5%) | $8.79B(+17.5%) |
| Sep 2000 | - | $2.52B(+13.3%) | $7.48B(+16.5%) |
| Jun 2000 | - | $2.23B(+40.3%) | $6.42B(+19.3%) |
| Mar 2000 | - | $1.59B(+38.5%) | $5.38B(+6.0%) |
| Dec 1999 | $5.07B(+23.1%) | $1.15B(-21.7%) | $5.08B(+5.8%) |
| Sep 1999 | - | $1.46B(+23.3%) | $4.80B(+6.8%) |
| Jun 1999 | - | $1.19B(-7.6%) | $4.50B(+1.8%) |
| Mar 1999 | - | $1.28B(+47.8%) | $4.42B(+4.6%) |
| Dec 1998 | $4.12B(+8.2%) | $869.00M(-25.0%) | $4.23B(+0.5%) |
| Sep 1998 | - | $1.16B(+4.7%) | $4.20B(+5.1%) |
| Jun 1998 | - | $1.11B(+1.5%) | $4.00B(+7.5%) |
| Mar 1998 | - | $1.09B(+28.8%) | $3.72B(+1.3%) |
| Dec 1997 | $3.81B(+9.7%) | $847.00M(-11.2%) | $3.67B(+10.0%) |
| Sep 1997 | - | $954.00M(+15.4%) | $3.34B(+0.5%) |
| Jun 1997 | - | $827.00M(-20.8%) | $3.32B(+4.6%) |
| Mar 1997 | - | $1.04B(+103.1%) | $3.17B(+4.4%) |
| Dec 1996 | $3.47B(+16.6%) | $514.00M(-45.1%) | $3.04B(-8.1%) |
| Sep 1996 | - | $937.00M(+37.8%) | $3.31B(+5.1%) |
| Jun 1996 | - | $680.00M(-25.3%) | $3.15B(+1.7%) |
| Mar 1996 | - | $910.00M(+16.4%) | $3.10B(+5.6%) |
| Dec 1995 | $2.97B(+31.4%) | $781.60M(+0.6%) | $2.93B(+7.3%) |
| Sep 1995 | - | $776.70M(+23.9%) | $2.73B(+7.7%) |
| Jun 1995 | - | $626.90M(-16.0%) | $2.54B(+6.7%) |
| Mar 1995 | - | $746.50M(+28.4%) | $2.38B(+4.9%) |
| Dec 1994 | $2.26B(+17.7%) | $581.30M(+0.1%) | $2.27B(+61.2%) |
| Sep 1994 | - | $581.00M(+24.4%) | $1.41B(+5.0%) |
| Jun 1994 | - | $466.90M(-26.7%) | $1.34B(-10.1%) |
| Mar 1994 | - | $636.60M(+328.5%) | $1.49B(+6.2%) |
| Dec 1993 | $1.92B(+12.7%) | -$278.60M(-154.2%) | $1.40B(-33.3%) |
| Sep 1993 | - | $514.20M(-16.6%) | $2.10B(+2.1%) |
| Jun 1993 | - | $616.80M(+12.2%) | $2.06B(+15.6%) |
| Mar 1993 | - | $549.90M(+30.3%) | $1.78B(+4.4%) |
| Dec 1992 | $1.71B(+14.0%) | $422.00M(-10.6%) | $1.71B(+6.3%) |
| Sep 1992 | - | $471.90M(+39.2%) | $1.61B(+2.4%) |
| Jun 1992 | - | $338.90M(-28.6%) | $1.57B(+2.0%) |
| Mar 1992 | - | $474.50M(+48.0%) | $1.54B(+2.7%) |
| Dec 1991 | $1.50B(+17.1%) | $320.50M(-26.3%) | $1.50B(+3.7%) |
| Sep 1991 | - | $434.80M(+40.8%) | $1.44B(+3.6%) |
| Jun 1991 | - | $308.70M(-28.9%) | $1.39B(+3.2%) |
| Mar 1991 | - | $434.00M(+62.6%) | $1.35B(+5.6%) |
| Dec 1990 | $1.28B(+8.8%) | $266.90M(-30.7%) | $1.28B(+158.3%) |
| Sep 1990 | - | $385.20M(+45.2%) | -$2.20B(-92.1%) |
| Jun 1990 | - | $265.20M(-26.8%) | -$1.14B(-982.5%) |
| Mar 1990 | - | $362.50M(+111.3%) | -$105.60M(-110.9%) |
| Dec 1989 | $1.18B(-2.6%) | -$3.21B(-323.1%) | $968.20M(-17.4%) |
| Sep 1989 | - | $1.44B(+10.4%) | $1.17B(+5.0%) |
| Jun 1989 | - | $1.30B(-9.3%) | $1.12B(-2.9%) |
| Mar 1989 | - | $1.44B(+147.8%) | $1.15B(+13.7%) |
| Dec 1988 | $1.21B(+9.4%) | -$3.01B(-317.3%) | $1.01B(-23.0%) |
| Sep 1988 | - | $1.38B(+3.5%) | $1.31B(+6.9%) |
| Jun 1988 | - | $1.34B(+3.0%) | $1.23B(+9.8%) |
| Mar 1988 | - | $1.30B(+148.0%) | $1.12B(+19.0%) |
| Dec 1987 | $1.10B(-0.4%) | -$2.70B(-308.3%) | $940.80M(-27.1%) |
| Sep 1987 | - | $1.30B(+5.8%) | $1.29B(+11.7%) |
| Jun 1987 | - | $1.23B(+9.6%) | $1.16B(+10.4%) |
| Mar 1987 | - | $1.12B(+147.6%) | $1.05B(+9.1%) |
| Dec 1986 | $1.11B(+9.6%) | -$2.35B(-302.3%) | $959.70M(-21.8%) |
| Sep 1986 | - | $1.16B(+4.0%) | $1.23B(+14.0%) |
| Jun 1986 | - | $1.12B(+8.3%) | $1.08B(+12.1%) |
| Mar 1986 | - | $1.03B(+149.5%) | $960.20M(+9.9%) |
| Dec 1985 | $1.01B(+5.1%) | -$2.09B(-306.0%) | $873.80M(-3.5%) |
| Sep 1985 | - | $1.01B(+1.1%) | $905.70M(+3.4%) |
| Jun 1985 | - | $1.00B(+5.9%) | $875.60M(+1.9%) |
| Mar 1985 | - | $945.70M(+146.0%) | $859.40M(+3.1%) |
| Dec 1984 | $960.30M(+10.1%) | -$2.05B(-309.1%) | $833.50M(-71.1%) |
| Sep 1984 | - | $982.70M(-0.3%) | $2.89B(+51.6%) |
| Jun 1984 | - | $985.70M(+7.2%) | $1.91B(+107.2%) |
| Mar 1984 | - | $919.80M | $919.80M |
| Dec 1983 | $872.10M(+22.5%) | - | - |
| Dec 1982 | $712.00M(+16.6%) | - | - |
| Dec 1981 | $610.50M(+5.9%) | - | - |
| Dec 1980 | $576.70M | - | - |
FAQ
- What is Pfizer Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Pfizer Inc.?
- What is Pfizer Inc. annual EBITDA year-on-year change?
- What is Pfizer Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Pfizer Inc.?
- What is Pfizer Inc. quarterly EBITDA year-on-year change?
- What is Pfizer Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Pfizer Inc.?
- What is Pfizer Inc. TTM EBITDA year-on-year change?
What is Pfizer Inc. annual EBITDA?
The current annual EBITDA of PFE is $23.50B
What is the all-time high annual EBITDA for Pfizer Inc.?
Pfizer Inc. all-time high annual EBITDA is $42.61B
What is Pfizer Inc. annual EBITDA year-on-year change?
Over the past year, PFE annual EBITDA has changed by +$11.91B (+102.87%)
What is Pfizer Inc. quarterly EBITDA?
The current quarterly EBITDA of PFE is $7.19B
What is the all-time high quarterly EBITDA for Pfizer Inc.?
Pfizer Inc. all-time high quarterly EBITDA is $14.12B
What is Pfizer Inc. quarterly EBITDA year-on-year change?
Over the past year, PFE quarterly EBITDA has changed by +$469.00M (+6.98%)
What is Pfizer Inc. TTM EBITDA?
The current TTM EBITDA of PFE is $26.15B
What is the all-time high TTM EBITDA for Pfizer Inc.?
Pfizer Inc. all-time high TTM EBITDA is $43.10B
What is Pfizer Inc. TTM EBITDA year-on-year change?
Over the past year, PFE TTM EBITDA has changed by +$9.12B (+53.51%)